We are live on ! Find out more
LP

Longview Partners Portfolio holdings

AUM $7.06B
1-Year Est. Return 3.43%
This Fund
S&P 500
This Quarter Est. Return
+10.75%
1 Year Est. Return
-3.43%
3 Year Est. Return
+28.48%
5 Year Est. Return
+46.59%
10 Year Est. Return
+218.87%
AUM
$19B
AUM Growth
+$196M
Cap. Flow
-$1.65B
Cap. Flow %
-8.69%
Top 10 Hldgs %
54.61%
Holding
27
New
–
Increased
8
Reduced
17
Closed
2

Top Buys

Rank Stock Value
1
STT icon
State Street
STT
+$290M
2
WFC icon
Wells Fargo
WFC
+$227M
3
BNY
Bank of New York Mellon
BNY
+$135M
4
EMR icon
Emerson Electric
EMR
+$109M
5
GWW icon
W.W. Grainger
GWW
+$75.2M

Top Sells

Rank Stock Value
1
ZBH icon
Zimmer Biomet
ZBH
+$486M
2
DG icon
Dollar General
DG
+$478M
3
IQV icon
IQVIA
IQV
+$416M
4
PFE icon
Pfizer
PFE
+$372M
5
TMO icon
Thermo Fisher Scientific
TMO
+$332M

Sector Composition

Rank Sector Weight
1 Healthcare 28.67%
2 Financials 26.85%
3 Industrials 16.2%
4 Technology 12.96%
5 Communication Services 7.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HCA icon
1
HCA Healthcare
HCA
$92.8B
$1.13B 5.96%
8,673,776
-321,249
-4% -$43.1M
WTW icon
2
Willis Towers Watson
WTW
$29.9B
$1.05B 5.53%
5,972,827
-140,065
-2% -$23.2M
FIS icon
3
Fidelity National Information Services
FIS
$23.2B
$1.04B 5.49%
9,212,311
-471,714
-5% -$50.3M
PH icon
4
Parker-Hannifin
PH
$125B
$1.03B 5.45%
6,026,434
+400,317
+7% +$66.4M
GWW icon
5
W.W. Grainger
GWW
$66B
$1.03B 5.4%
3,408,362
+252,968
+8% +$75.2M
ORCL icon
6
Oracle
ORCL
$346B
$1.02B 5.38%
19,023,463
-39,686
-0.2% -$2.02M
AON icon
7
Aon
AON
$81.4B
$1.02B 5.37%
5,971,367
-247,452
-4% -$40.1M
WFC icon
8
Wells Fargo
WFC
$263B
$1.02B 5.35%
21,032,018
+4,625,096
+28% +$227M
EMR icon
9
Emerson Electric
EMR
$85B
$1.02B 5.35%
14,829,592
+1,659,256
+13% +$109M
BNY
10
Bank of New York Mellon
BNY
$106B
$1.01B 5.34%
20,093,549
+2,627,926
+15% +$135M
STT icon
11
State Street
STT
$50.2B
$1B 5.27%
15,195,595
+4,189,902
+38% +$290M
CHTR icon
12
Charter Communications
CHTR
$16.7B
$991M 5.22%
2,857,174
-113,983
-4% -$37.5M
AGN
13
DELISTED
Allergan plc
AGN
$924M 4.87%
6,309,795
+283,687
+5% +$41.1M
IQV icon
14
IQVIA
IQV
$40B
$894M 4.71%
6,213,751
-3,118,116
-33% -$416M
UNH icon
15
UnitedHealth
UNH
$389B
$844M 4.45%
3,414,533
-130,322
-4% -$33.2M
HSIC icon
16
Henry Schein
HSIC
$9.76B
$806M 4.25%
13,409,372
-3,444,408
-20% -$208M
MDT icon
17
Medtronic
MDT
$111B
$552M 2.91%
6,056,278
-297,177
-5% -$26.6M
DG icon
18
Dollar General
DG
$27.8B
$549M 2.89%
4,598,111
-4,105,504
-47% -$478M
USFD icon
19
US Foods
USFD
$22.3B
$529M 2.79%
15,162,898
-567,478
-4% -$19.5M
OMC icon
20
Omnicom Group
OMC
$24.6B
$489M 2.58%
6,698,771
-146,072
-2% -$11M
ZBH icon
21
Zimmer Biomet
ZBH
$18.5B
$294M 1.55%
2,368,992
-4,275,564
-64% -$486M
TJX icon
22
TJX Companies
TJX
$178B
$243M 1.28%
4,566,722
-174,358
-4% -$8.69M
ARW icon
23
Arrow Electronics
ARW
$10.8B
$222M 1.17%
2,883,727
+17,546
+0.6% +$1.35M
FISV
24
Fiserv Inc
FISV
$28.9B
$175M 0.92%
1,986,108
-75,458
-4% -$6.23M
FTDR icon
25
Frontdoor
FTDR
$5.22B
$106M 0.56%
3,084,280
-110,056
-3% -$3.36M
1
2

Similar funds

IGAM
iA Global Asset Management Quebec, Quebec, Canada $7.06B AUM 28.93% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
RPI
Railway Pension Investments London, United Kingdom $7.03B AUM 18.92% 1-Year Est. Return
MNA
Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return
CWM
Circle Wealth Management Summit, New Jersey $7.02B AUM 19.32% 1-Year Est. Return
SC
Saturna Capital Bellingham, Washington $7.13B AUM 35.47% 1-Year Est. Return
OCA
OpenArc Corporate Advisory Atlanta, Georgia $6.98B AUM
DE
Defiance ETFs New York $6.98B AUM

Longview Partners's Q1 2019 Portfolio in Review

As of Q1 2019, Longview Partners held 27 positions worth $19B, up 1% from $18.8B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Longview Partners withdrew a net $1.65B in Q1 2019, closing 2 positions and reducing 17 holdings. Its most notable exit was Pfizer, an estimated $372M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 37% a quarter earlier, followed by Financials and Industrials.

Against the trend, Longview Partners added an estimated $290M to State Street.

  • Longview Partners added most to State Street in Q1 2019, an estimated $290M increase.
  • Longview Partners's biggest Q1 2019 reduction was Zimmer Biomet, cutting an estimated $486M.
  • Longview Partners fully exited Pfizer in Q1 2019, selling an estimated $372M.
  • Longview Partners's ten largest holdings make up 55% of its $19B portfolio in Q1 2019.
  • Longview Partners opened 0 new positions and closed 2 in Q1 2019.
  • Longview Partners's portfolio value rose 1% quarter-over-quarter to $19B.

Based on Longview Partners's 13F filing for Q1 2019, filed 15 May 2019.